OncoCyte Corp.
(NYSE Amex Equities : OCX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-0.09%97.870.6%$565.19m
ISRGIntuitive Surgical, Inc.
-0.26%515.952.4%$396.45m
ABTAbbott Laboratories
-0.31%83.160.8%$394.60m
TMOThermo Fisher Scientific Inc.
-0.17%288.711.0%$382.52m
BSXBoston Scientific Corporation
-0.12%40.891.1%$316.22m
BDXBecton, Dickinson and Company
0.14%236.901.1%$289.52m
ALGNAlign Technology, Inc.
-0.65%288.196.3%$274.67m
EWEdwards Lifesciences Corporation
0.36%190.001.2%$221.49m
DXCMDexCom, Inc.
-0.25%152.168.3%$204.03m
SYKStryker Corporation
0.03%198.251.3%$196.21m
BAXBaxter International Inc.
-0.43%80.211.7%$181.28m
ABMDABIOMED, Inc.
0.28%257.193.3%$165.78m
ZBHZimmer Biomet Holdings, Inc.
-0.25%117.831.7%$117.14m
WATWaters Corporation
-0.24%207.553.8%$116.19m
PKIPerkinElmer, Inc.
0.03%94.522.7%$100.19m

Company Profile

OncoCyte Corp. is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA.